{"data":[{"accessionNo":"0001104659-26-097271","formType":"SCHEDULE 13G/A","amendmentNo":10,"issuerCik":"0001766140","issuerName":"Unicycive Therapeutics, Inc.","ticker":"UNCY","cusip":"90466Y202","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-30","reportingPerson":"Wilmot B. Harkey","reportingCik":null,"personType":"HC","sharesOwned":2807830,"percentOfClass":9.99,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/uncy"},{"accessionNo":"0001104659-26-097271","formType":"SCHEDULE 13G/A","amendmentNo":10,"issuerCik":"0001766140","issuerName":"Unicycive Therapeutics, Inc.","ticker":"UNCY","cusip":"90466Y202","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-30","reportingPerson":"Nantahala Capital Management, LLC","reportingCik":null,"personType":"IA","sharesOwned":2807830,"percentOfClass":9.99,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/uncy"},{"accessionNo":"0001104659-26-097271","formType":"SCHEDULE 13G/A","amendmentNo":10,"issuerCik":"0001766140","issuerName":"Unicycive Therapeutics, Inc.","ticker":"UNCY","cusip":"90466Y202","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-30","reportingPerson":"Daniel Mack","reportingCik":null,"personType":"HC","sharesOwned":2807830,"percentOfClass":9.99,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/uncy"},{"accessionNo":"0001213900-26-090075","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001766140","issuerName":"Unicycive Therapeutics, Inc.","ticker":"UNCY","cusip":"90466Y202","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-06-30","reportingPerson":"Vivo Opportunity Fund Holdings, L.P.","reportingCik":null,"personType":"PN","sharesOwned":4856259,"percentOfClass":9.99,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/uncy"},{"accessionNo":"0001213900-26-090075","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001766140","issuerName":"Unicycive Therapeutics, Inc.","ticker":"UNCY","cusip":"90466Y202","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-06-30","reportingPerson":"Vivo Opportunity, LLC","reportingCik":null,"personType":"OO","sharesOwned":4856259,"percentOfClass":9.99,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/uncy"},{"accessionNo":"0002012383-26-003117","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001766140","issuerName":"UNICYCIVE THERAPEUTICS INC","ticker":"UNCY","cusip":"90466Y202","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":1413381,"percentOfClass":5.3,"filedAt":"2026-07-30","canonicalUrl":"https://xoomar.com/markets/stocks/uncy"},{"accessionNo":"0001104659-26-081878","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001766140","issuerName":"Unicycive Therapeutics, Inc.","ticker":"UNCY","cusip":"90466Y202","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-30","reportingPerson":"Israel A. Englander","reportingCik":null,"personType":"IN","sharesOwned":271456,"percentOfClass":1,"filedAt":"2026-07-08","canonicalUrl":"https://xoomar.com/markets/stocks/uncy"},{"accessionNo":"0001104659-26-081878","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001766140","issuerName":"Unicycive Therapeutics, Inc.","ticker":"UNCY","cusip":"90466Y202","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-30","reportingPerson":"Millennium Group Management LLC","reportingCik":null,"personType":"OO","sharesOwned":271456,"percentOfClass":1,"filedAt":"2026-07-08","canonicalUrl":"https://xoomar.com/markets/stocks/uncy"},{"accessionNo":"0001104659-26-081878","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001766140","issuerName":"Unicycive Therapeutics, Inc.","ticker":"UNCY","cusip":"90466Y202","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-30","reportingPerson":"Millennium Management LLC","reportingCik":null,"personType":"OO","sharesOwned":271456,"percentOfClass":1,"filedAt":"2026-07-08","canonicalUrl":"https://xoomar.com/markets/stocks/uncy"},{"accessionNo":"0001104659-26-081878","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001766140","issuerName":"Unicycive Therapeutics, Inc.","ticker":"UNCY","cusip":"90466Y202","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-30","reportingPerson":"Integrated Core Strategies (US) LLC","reportingCik":null,"personType":"OO","sharesOwned":205529,"percentOfClass":0.8,"filedAt":"2026-07-08","canonicalUrl":"https://xoomar.com/markets/stocks/uncy"},{"accessionNo":"0001346824-26-000159","formType":"SCHEDULE 13G/A","amendmentNo":7,"issuerCik":"0001766140","issuerName":"Unicycive Therapeutics, Inc.","ticker":"UNCY","cusip":"90466Y202","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-03-31","reportingPerson":"Rajeev Shah","reportingCik":null,"personType":"HC,IN","sharesOwned":2801082,"percentOfClass":9.9,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/uncy"},{"accessionNo":"0001346824-26-000159","formType":"SCHEDULE 13G/A","amendmentNo":7,"issuerCik":"0001766140","issuerName":"Unicycive Therapeutics, Inc.","ticker":"UNCY","cusip":"90466Y202","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-03-31","reportingPerson":"RA Capital Healthcare Fund, L.P.","reportingCik":null,"personType":"PN","sharesOwned":2801082,"percentOfClass":9.9,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/uncy"},{"accessionNo":"0001346824-26-000159","formType":"SCHEDULE 13G/A","amendmentNo":7,"issuerCik":"0001766140","issuerName":"Unicycive Therapeutics, Inc.","ticker":"UNCY","cusip":"90466Y202","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-03-31","reportingPerson":"Peter Kolchinsky","reportingCik":null,"personType":"HC,IN","sharesOwned":2801082,"percentOfClass":9.9,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/uncy"},{"accessionNo":"0001346824-26-000159","formType":"SCHEDULE 13G/A","amendmentNo":7,"issuerCik":"0001766140","issuerName":"Unicycive Therapeutics, Inc.","ticker":"UNCY","cusip":"90466Y202","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-03-31","reportingPerson":"RA Capital Management, L.P.","reportingCik":null,"personType":"IA,PN","sharesOwned":2801082,"percentOfClass":9.9,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/uncy"},{"accessionNo":"0001346824-26-000059","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001766140","issuerName":"Unicycive Therapeutics, Inc.","ticker":"UNCY","cusip":null,"securityClass":"Common Stock, $0.001 par value per share","eventDate":"2025-12-31","reportingPerson":"RA Capital Management, L.P.","reportingCik":null,"personType":"IA,PN","sharesOwned":2385279,"percentOfClass":9.9,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/uncy"},{"accessionNo":"0001346824-26-000059","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001766140","issuerName":"Unicycive Therapeutics, Inc.","ticker":"UNCY","cusip":null,"securityClass":"Common Stock, $0.001 par value per share","eventDate":"2025-12-31","reportingPerson":"Peter Kolchinsky","reportingCik":null,"personType":"HC,IN","sharesOwned":2385279,"percentOfClass":9.9,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/uncy"},{"accessionNo":"0001346824-26-000059","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001766140","issuerName":"Unicycive Therapeutics, Inc.","ticker":"UNCY","cusip":null,"securityClass":"Common Stock, $0.001 par value per share","eventDate":"2025-12-31","reportingPerson":"Rajeev Shah","reportingCik":null,"personType":"HC,IN","sharesOwned":2385279,"percentOfClass":9.9,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/uncy"},{"accessionNo":"0001346824-26-000059","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001766140","issuerName":"Unicycive Therapeutics, Inc.","ticker":"UNCY","cusip":null,"securityClass":"Common Stock, $0.001 par value per share","eventDate":"2025-12-31","reportingPerson":"RA Capital Healthcare Fund, L.P.","reportingCik":null,"personType":"PN","sharesOwned":2385279,"percentOfClass":9.9,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/uncy"},{"accessionNo":"0001104659-26-015349","formType":"SCHEDULE 13G/A","amendmentNo":9,"issuerCik":"0001766140","issuerName":"UNICYCIVE THERAPEUTICS, INC.","ticker":"UNCY","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-12-31","reportingPerson":"Nantahala Capital Management, LLC","reportingCik":null,"personType":"IA","sharesOwned":2281040,"percentOfClass":9.99,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/uncy"},{"accessionNo":"0001104659-26-015349","formType":"SCHEDULE 13G/A","amendmentNo":9,"issuerCik":"0001766140","issuerName":"UNICYCIVE THERAPEUTICS, INC.","ticker":"UNCY","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-12-31","reportingPerson":"Wilmot B. Harkey","reportingCik":null,"personType":"HC","sharesOwned":2281040,"percentOfClass":9.99,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/uncy"},{"accessionNo":"0001104659-26-015349","formType":"SCHEDULE 13G/A","amendmentNo":9,"issuerCik":"0001766140","issuerName":"UNICYCIVE THERAPEUTICS, INC.","ticker":"UNCY","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-12-31","reportingPerson":"Daniel Mack","reportingCik":null,"personType":"HC","sharesOwned":2281040,"percentOfClass":9.99,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/uncy"},{"accessionNo":"0001214659-26-001398","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001766140","issuerName":"Unicycive Therapeutics, Inc.","ticker":"UNCY","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2025-12-31","reportingPerson":"Octagon Capital Advisors LP","reportingCik":null,"personType":"IA,PN","sharesOwned":1000000,"percentOfClass":4.7,"filedAt":"2026-02-10","canonicalUrl":"https://xoomar.com/markets/stocks/uncy"},{"accessionNo":"0001214659-26-001398","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001766140","issuerName":"Unicycive Therapeutics, Inc.","ticker":"UNCY","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2025-12-31","reportingPerson":"Ting Jia","reportingCik":null,"personType":"HC,IN","sharesOwned":1000000,"percentOfClass":4.7,"filedAt":"2026-02-10","canonicalUrl":"https://xoomar.com/markets/stocks/uncy"},{"accessionNo":"0001214659-26-001398","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001766140","issuerName":"Unicycive Therapeutics, Inc.","ticker":"UNCY","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2025-12-31","reportingPerson":"Octagon Investments Master Fund LP","reportingCik":null,"personType":"PN,OO","sharesOwned":650000,"percentOfClass":3,"filedAt":"2026-02-10","canonicalUrl":"https://xoomar.com/markets/stocks/uncy"},{"accessionNo":"0001214659-26-001398","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001766140","issuerName":"Unicycive Therapeutics, Inc.","ticker":"UNCY","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2025-12-31","reportingPerson":"Octagon Biotech Opportunities Fund I LP","reportingCik":null,"personType":"PN,OO","sharesOwned":350000,"percentOfClass":1.7,"filedAt":"2026-02-10","canonicalUrl":"https://xoomar.com/markets/stocks/uncy"},{"accessionNo":"0001104659-26-006264","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001766140","issuerName":"Unicycive Therapeutics, Inc.","ticker":"UNCY","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-01-16","reportingPerson":"Integrated Core Strategies (US) LLC","reportingCik":null,"personType":"OO","sharesOwned":1172667,"percentOfClass":5.5,"filedAt":"2026-01-23","canonicalUrl":"https://xoomar.com/markets/stocks/uncy"},{"accessionNo":"0001104659-26-006264","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001766140","issuerName":"Unicycive Therapeutics, Inc.","ticker":"UNCY","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-01-16","reportingPerson":"Millennium Management LLC","reportingCik":null,"personType":"OO","sharesOwned":1172667,"percentOfClass":5.5,"filedAt":"2026-01-23","canonicalUrl":"https://xoomar.com/markets/stocks/uncy"},{"accessionNo":"0001104659-26-006264","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001766140","issuerName":"Unicycive Therapeutics, Inc.","ticker":"UNCY","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-01-16","reportingPerson":"Millennium Group Management LLC","reportingCik":null,"personType":"OO","sharesOwned":1172667,"percentOfClass":5.5,"filedAt":"2026-01-23","canonicalUrl":"https://xoomar.com/markets/stocks/uncy"},{"accessionNo":"0001104659-26-006264","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001766140","issuerName":"Unicycive Therapeutics, Inc.","ticker":"UNCY","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-01-16","reportingPerson":"Israel A. Englander","reportingCik":null,"personType":"IN","sharesOwned":1172667,"percentOfClass":5.5,"filedAt":"2026-01-23","canonicalUrl":"https://xoomar.com/markets/stocks/uncy"},{"accessionNo":"0001213900-25-111132","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001766140","issuerName":"Unicycive Therapeutics, Inc.","ticker":"UNCY","cusip":null,"securityClass":"Common Stock, $0.001 par value per share","eventDate":"2025-09-30","reportingPerson":"Vivo Opportunity, LLC","reportingCik":null,"personType":"OO","sharesOwned":6096175,"percentOfClass":9.99,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/uncy"},{"accessionNo":"0001104659-25-112646","formType":"SCHEDULE 13G/A","amendmentNo":8,"issuerCik":"0001766140","issuerName":"UNICYCIVE THERAPEUTICS, INC.","ticker":"UNCY","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"Nantahala Capital Management, LLC","reportingCik":null,"personType":"IA","sharesOwned":1855991,"percentOfClass":9.99,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/uncy"},{"accessionNo":"0001104659-25-112646","formType":"SCHEDULE 13G/A","amendmentNo":8,"issuerCik":"0001766140","issuerName":"UNICYCIVE THERAPEUTICS, INC.","ticker":"UNCY","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"Wilmot B. Harkey","reportingCik":null,"personType":"HC","sharesOwned":1855991,"percentOfClass":9.99,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/uncy"},{"accessionNo":"0001104659-25-112646","formType":"SCHEDULE 13G/A","amendmentNo":8,"issuerCik":"0001766140","issuerName":"UNICYCIVE THERAPEUTICS, INC.","ticker":"UNCY","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"Daniel Mack","reportingCik":null,"personType":"HC","sharesOwned":1855991,"percentOfClass":9.99,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/uncy"},{"accessionNo":"0001213900-25-111132","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001766140","issuerName":"Unicycive Therapeutics, Inc.","ticker":"UNCY","cusip":null,"securityClass":"Common Stock, $0.001 par value per share","eventDate":"2025-09-30","reportingPerson":"Vivo Opportunity Fund Holdings, L.P.","reportingCik":null,"personType":"PN","sharesOwned":6096175,"percentOfClass":9.99,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/uncy"},{"accessionNo":"0001231919-25-000493","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001766140","issuerName":"Unicycive Therapeutics, Inc.","ticker":"UNCY","cusip":null,"securityClass":"Common Stock, $0.001 par value per share","eventDate":"2025-09-30","reportingPerson":"RA Capital Healthcare Fund, L.P.","reportingCik":null,"personType":"PN","sharesOwned":1960230,"percentOfClass":9.9,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/uncy"},{"accessionNo":"0001231919-25-000493","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001766140","issuerName":"Unicycive Therapeutics, Inc.","ticker":"UNCY","cusip":null,"securityClass":"Common Stock, $0.001 par value per share","eventDate":"2025-09-30","reportingPerson":"RA Capital Management, L.P.","reportingCik":null,"personType":"IA,PN","sharesOwned":1960230,"percentOfClass":9.9,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/uncy"},{"accessionNo":"0001231919-25-000493","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001766140","issuerName":"Unicycive Therapeutics, Inc.","ticker":"UNCY","cusip":null,"securityClass":"Common Stock, $0.001 par value per share","eventDate":"2025-09-30","reportingPerson":"Peter Kolchinsky","reportingCik":null,"personType":"HC,IN","sharesOwned":1960230,"percentOfClass":9.9,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/uncy"},{"accessionNo":"0001231919-25-000493","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001766140","issuerName":"Unicycive Therapeutics, Inc.","ticker":"UNCY","cusip":null,"securityClass":"Common Stock, $0.001 par value per share","eventDate":"2025-09-30","reportingPerson":"Rajeev Shah","reportingCik":null,"personType":"HC,IN","sharesOwned":1960230,"percentOfClass":9.9,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/uncy"},{"accessionNo":"0001214659-25-016719","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001766140","issuerName":"Unicycive Therapeutics, Inc.","ticker":"UNCY","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2025-09-30","reportingPerson":"Ting Jia","reportingCik":null,"personType":"IN","sharesOwned":1000000,"percentOfClass":5.7,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/uncy"},{"accessionNo":"0001214659-25-016719","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001766140","issuerName":"Unicycive Therapeutics, Inc.","ticker":"UNCY","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2025-09-30","reportingPerson":"Octagon Capital Advisors LP","reportingCik":null,"personType":"IA,PN","sharesOwned":1000000,"percentOfClass":5.7,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/uncy"},{"accessionNo":"0001814554-25-000178","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001766140","issuerName":"Unicycive Therapeutics, Inc.","ticker":"UNCY","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"Great Point Partners, LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":796558,"percentOfClass":4.51,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/uncy"},{"accessionNo":"0001814554-25-000178","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001766140","issuerName":"Unicycive Therapeutics, Inc.","ticker":"UNCY","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"Dr. Jeffrey R. Jay, M.D.","reportingCik":null,"personType":"HC,IN","sharesOwned":796558,"percentOfClass":4.51,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/uncy"},{"accessionNo":"0001814554-25-000178","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001766140","issuerName":"Unicycive Therapeutics, Inc.","ticker":"UNCY","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"Ms. Lillian Nordahl","reportingCik":null,"personType":"HC,IN","sharesOwned":796558,"percentOfClass":4.51,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/uncy"},{"accessionNo":"0001214659-25-016719","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001766140","issuerName":"Unicycive Therapeutics, Inc.","ticker":"UNCY","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2025-09-30","reportingPerson":"Octagon Investments Master Fund LP","reportingCik":null,"personType":"PN,OO","sharesOwned":650000,"percentOfClass":3.7,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/uncy"},{"accessionNo":"0001214659-25-016719","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001766140","issuerName":"Unicycive Therapeutics, Inc.","ticker":"UNCY","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2025-09-30","reportingPerson":"Octagon Private Opportunities Fund II LP","reportingCik":null,"personType":"PN,OO","sharesOwned":350000,"percentOfClass":2,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/uncy"}],"updatedAt":"2026-10-26T00:42:32.237Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/uncy","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}